Tri Chemical Laboratories Inc.
Tri Chemical Laboratories Inc. Fundamental Analysis
Tri Chemical Laboratories Inc. (4369.T) shows strong financial fundamentals with a PE ratio of 16.03, profit margin of 23.09%, and ROE of 16.31%. The company generates $23.9B in annual revenue with strong year-over-year growth of 68.11%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -34.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 4369.T's fundamental strength across five key dimensions:
Efficiency Score
Excellent4369.T demonstrates superior asset utilization.
Valuation Score
Excellent4369.T trades at attractive valuation levels.
Growth Score
Moderate4369.T shows steady but slowing expansion.
Financial Health Score
Excellent4369.T maintains a strong and stable balance sheet.
Profitability Score
Moderate4369.T maintains healthy but balanced margins.
Key Financial Metrics
Is 4369.T Expensive or Cheap?
P/E Ratio
4369.T trades at 16.03 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 4369.T's PEG of -3.82 indicates potential undervaluation.
Price to Book
The market values Tri Chemical Laboratories Inc. at 2.45 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 11.71 times EBITDA. This signals the market has high growth expectations.
How Well Does 4369.T Make Money?
Net Profit Margin
For every $100 in sales, Tri Chemical Laboratories Inc. keeps $23.09 as profit after all expenses.
Operating Margin
Core operations generate 24.71 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $16.31 in profit for every $100 of shareholder equity.
ROA
Tri Chemical Laboratories Inc. generates $11.67 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Tri Chemical Laboratories Inc. produces operating cash flow of $3.80B, showing steady but balanced cash generation.
Free Cash Flow
Tri Chemical Laboratories Inc. generates weak or negative free cash flow of $-2.49B, restricting financial flexibility.
FCF Per Share
Each share generates $-76.66 in free cash annually.
FCF Yield
4369.T converts -2.82% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
16.03
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-3.82
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.45
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.70
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.11
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.06
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.16
vs 25 benchmark
ROA
Return on assets percentage
0.12
vs 25 benchmark
ROCE
Return on capital employed
0.15
vs 25 benchmark
How 4369.T Stacks Against Its Sector Peers
| Metric | 4369.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 16.03 | 24.08 | Better (Cheaper) |
| ROE | 16.31% | 921.00% | Weak |
| Net Margin | 23.09% | -113338.00% (disorted) | Strong |
| Debt/Equity | 0.11 | 0.53 | Strong (Low Leverage) |
| Current Ratio | 3.06 | 5.09 | Strong Liquidity |
| ROA | 11.67% | -9816.00% (disorted) | Strong |
4369.T outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Tri Chemical Laboratories Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
119.89%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
62.30%
Industry Style: Cyclical, Commodity, Value
High GrowthFCF CAGR
95.25%
Industry Style: Cyclical, Commodity, Value
High Growth